Advisory Committees Recommend New Vaccines and Address Thimerosal Concerns
New recommendations from advisory committees include a monoclonal antibody for RSV and restrictions on thimerosal in flu vaccines, despite general support for vaccinations.
Washington ExaminerRFK Jr. vaccine panel nixes thimerosal in flu shots
The GuardianRFK Jr’s new vaccine panel votes against preservative in flu shots in shock move
Boston HeraldKennedy’s advisers endorse flu vaccines — except for a few targeted by antivaccine activists
CBS NewsRFK Jr.'s vaccine committee votes on new RSV immunization, flu shots
Overview
Advisory committees recommend new vaccines and treatments for infants against RSV, including Merck's monoclonal antibody Enflonsia.
Health Secretary Robert F. Kennedy Jr.'s committee is evaluating flu vaccines and the controversial preservative thimerosal.
Some advisory panels are advocating against thimerosal in multi-dose flu vaccines, despite studies showing no harm linked to it.
Annual flu vaccinations are endorsed for nearly all individuals over 6 months old, with exceptions targeted by antivaccine activists.
Members of Kennedy's panel voted to restrict thimerosal in seasonal influenza vaccines, aligning with recommendations from the Advisory Committee on Immunization Practices.
Analysis
Center-leaning sources express concern over the potential negative impact of thimerosal discussions on public confidence in vaccines, emphasizing the importance of accessibility and affordability. They highlight the committee's decisions while framing the debate around vaccine safety and efficacy, reflecting a cautious stance towards emerging health policies.